Although sedative-hypnotic drugs (e.g. barbiturates, benzodiazepines, tricyclic antidepressants, and new generation Z-drugs) – the analytes can be determined by gas chromatography-mass spectrometry (GC-MS) without derivatization, however, several problems are usually encountered for the trace level analysis. Losses of the analytes and peak tailing due to adsorption in the GC inlet device and/or an interaction of the analytes with active sites on the walls of the capillary column can be observed [1-4]. The GC-MS analysis is not sensitive enough for the determination of sedative-hypnotic drugs without derivatization [3-7]. Because the analytes are lipophilic compounds, they should be converted into volatile derivatives prior to GC analysis.
Consequently, for most GC-MS methods derivatization of sedative-hypnotic drugs improves spectral determination/definition and reduces thermal degradation on-column [1,3,4]. Thus, derivatization by different reagents: mixtures of N-methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA), N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1 % trimethylchlorosilane (TMCS), N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA) in acetonitrile and ethyl acetate were investigated. The derivatization procedure was optimized to obtain the highest sensitivity and repeatability of the derivatives and to avoid interferences from the sample matrix. The greatest peak areas of derivatized analytes were achieved by silylation using 100 μL of a mixture of MTBSTFA, acetonitrile, and ethyl acetate (at 20:40:40 v/v/v). A slightly lower sensitivity was observed after silylation by MSTFA if compared with BSTFA with 1 % TMCS. The peak areas of derivatized analytes using these reagents were smaller in comparison with MTBSTFA. Moreover, during silylation by MSTFA or BSTFA with 1 % TMCS many problems arose at the derivatization step because both reagents are very sensitive to humidity [2,4]. Subsequently, insufficient repeatability of MSTFA and BSTFA derivatives was observed.
After silylation by MTBSTFA, sedative-hypnotic drugs were readily converted to their corresponding tert-butyldimethylsilyl-derivatives (TBDMS), via an SN2 substitution reaction, which yielded a single derivative for each sedative-hypnotic drugs compound. In addition, TBDMS derivatives of the analytes are hydrolytically stable and less sensitive to humidity.
In the next step of research, the derivatization time and temperature were optimized. The derivatization conditions including temperature, which was fixed at 60, 70, 80, 85, 90, and 100 °C, and the duration of the reaction, which was defined at 20, 25, 30, 35, and 40 min were tested. The optimal conditions are presented in bold. During the optimization of the derivatization temperature, the peak areas of silylated analytes-TBDMS kept increasing with the increase of temperature until the maximum peak area was reached at 85 °C. After this point, an increase in temperature resulted in the decrease of the peak areas of some analytes.
The silylation efficiency of the analytes was tested as a function of time. The highest peak areas were achieved when the reaction was carried out for 30 min, and after that increasing reaction time resulted in a decrease in the peak areas of some analytes. An increase in reaction time from 25 to 30 min did not affect the peak areas of the most silylated analytes. Therefore, the derivatization time and temperature for a mixture of MTBSTFA, acetonitrile, and ethyl acetate (at 20:40:40 v/v/v) at 85 °C for 30 min were chosen for further optimization studies.
The fast chromatographic conditions were tested at: 220, 230, 240, 250, and 300 °C for injector temperature; 280, 290, 300 and 310 °C for detector temperature; 150, 170, 180 and 250 °C for initial column temperature; 290, 310, 325 and 340 °C for final column temperature; as well as 30, 40, 50 and 60 °C min-1 for the column temperature elevation rate. The optimal conditions are presented in bold and have been chosen based on the peak areas of the analytes derivatized with MTBSTFA and not derivatized, as well as on their resolution.
In conclusion, the derivatization reagent MTBSTFA, the derivatization time of 30 min, and the derivatization temperature at 85 °C were selected as the optimal derivatization condition for quantification of sedative-hypnotic drugs by GС-MS. This method will be used in my further investigations for the determination of the analytes in biological samples.